It has been found that the many peptides produced from the enzymatic hydrolysis of dietary proteins exhibit excellent DPP-IV inhibitory activities and show potential as a glucose-lowering therapy, with less adverse effects than synthetic drugs in T2DM [6]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.